Research & Press
Progress worth
following.
Researchers are exploring new ways to help the immune system recognize and fight cancer. Follow developments in personalized cancer vaccines and the growing story of The Greta Initiative.
The science in the news.
Moderna cancer vaccine stops melanoma returning: what's next for personalized treatments?
A late-stage melanoma trial offers encouraging evidence for personalized mRNA cancer vaccines, while important questions remain about their use in other cancers.
Read the article →Moderna, Merck breakthrough could usher in wave of cancer vaccines
A look at how individualized mRNA vaccines are designed around a patient's tumor and why researchers are studying the approach across cancer types.
Read the article →UF researcher launches novel immunotherapy trial for pediatric cancers
Researchers are testing an experimental mRNA-based approach in children with recurrent high-grade glioma and osteosarcoma, studying safety and immune responses.
Read the research update →Personalized vaccine shows promise against aggressive brain cancer
An early-stage study of a personalized DNA vaccine—not an mRNA vaccine—explores immune responses in adults with glioblastoma.
Read the research update →Greta in the press.
We're working to bring Greta's story to more people. As news coverage and interviews are published, we'll share them here.
Help tell Greta's story.
Are you a journalist, producer, or editor interested in learning more about Greta, the science, or The Greta Initiative? We welcome thoughtful inquiries.
Get in touch →The articles above describe research in different cancers and at different stages of development. These experimental approaches are not established treatments for Greta, and findings in one cancer do not guarantee results in another. The Greta Initiative is pursuing a personalized treatment designed around Greta's own tumor.